- Home
- PBYI vs ELMD Comparison
PBYI vs ELMD Comparison
Compare PBYI & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PBYI | ELMD |
|---|---|---|
| Founded | 2010 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.4M | 199.2M |
| IPO Year | 2011 | 2010 |
Fundamental Metrics
Financial Performance| Metric | PBYI | ELMD |
|---|---|---|
| Price | $5.88 | $23.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $36.00 |
| AVG Volume (30 Days) | ★ 467.8K | 92.5K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.55 |
| EPS | ★ 0.61 | 0.56 |
| Revenue | $27,685,000.00 | ★ $54,716,000.00 |
| Revenue This Year | N/A | $15.59 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | ★ $9.84 | $42.57 |
| Revenue Growth | N/A | ★ 13.83 |
| 52 Week Low | $2.58 | $17.73 |
| 52 Week High | $7.68 | $30.73 |
Technical Indicators
Market Signals| Indicator | PBYI | ELMD |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 37.65 |
| Support Level | $5.57 | $17.87 |
| Resistance Level | $7.25 | $25.52 |
| Average True Range (ATR) | 0.43 | 0.95 |
| MACD | -0.11 | 0.08 |
| Stochastic Oscillator | 17.89 | 9.17 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.